Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CHF | +10.70% | +17.65% | +46.34% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.34% | 4.05M | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.60% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+5.09% | 8.81B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Ascom Hires New CFO